Welcome to LookChem.com Sign In|Join Free
  • or
1H-Indazole-3,5-dicarboxylic acid, 5-methyl ester is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

797804-53-6

Post Buying Request

797804-53-6 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

797804-53-6 Usage

Derivative of indazole

A heterocyclic aromatic organic compound

Potential applications

Pharmaceutical and medicinal chemistry

Use as building block

In the synthesis of various heterocyclic compounds and drug molecules

Stability

Enhanced by the 5-methyl ester group, suitable for use in various chemical reactions

Biological activities and pharmacological properties

Of interest for further research and development in drug discovery and medicinal chemistry.

Check Digit Verification of cas no

The CAS Registry Mumber 797804-53-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,9,7,8,0 and 4 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 797804-53:
(8*7)+(7*9)+(6*7)+(5*8)+(4*0)+(3*4)+(2*5)+(1*3)=226
226 % 10 = 6
So 797804-53-6 is a valid CAS Registry Number.

797804-53-6Downstream Products

797804-53-6Relevant academic research and scientific papers

Indazole-derivatives as factor Xa inhibitors

-

Page 57, (2008/06/13)

The present invention relates to compounds of the formulae I and Ib wherein R0 ; R1 ; R2 ;Q; V, G and M have the meanings indicated in the claims. The compounds of the formula I are valuable pharmacologically active compounds. They exhibit a strong antithrombotic effect and are suitable, for example, for the therapy and prophylaxis of cardiovascular disorders like thromboembolic diseases or restenoses. They are reversible inhibitors of the blood clotting enzymes factor Xa (FXa) and/or factor VIIa (FVIIa), and can in general be applied in conditions in which an undesired activity of factor Xa and/or factor VIIa is present or for the cure or prevention of which an inhibition of factor Xa and/or factor VIIa is intended. The invention furthermore relates to processes for the preparation of compounds of the formulae I and Ib, their use, in particular as active ingredients in pharmaceuticals, and pharmaceutical preparations comprising them.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 797804-53-6